![conference banner](/images/conference-banner.jpeg)
[1]
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types.html Accessed January 21, 2021,
[3]
Prasher, P.; Sharma, M.; Zacconi, F.; Gupta, G.; Aljabali, A.A.; Mishra, V.; Tambuwala, M.M.; Kapoor, D.N.; Negi, P.; Pinto, T.J.A.; Singh, I.; Chellappan, D.K.; Dua, K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: A Comprehensive Review. Curr. Organic Chem., 2021, 25(6), 654-668.
[4]
Dadashpour, S.; Emami, S. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. Eur. J. Med. Chem., 2018, 150, 9-29.
[5]
Bansal, Y.; Minhas, R.; Singhal, A.; Arora, R.K.; Bansal, G. Benzimidazole: A multifacted nucelus for anticancer agents. Curr. Organic Chem., 2021, 25(6), 669-694.
[6]
Grover, P.; Bhardwaj, M.; Kapoor, G.; Mehta, L.; Ghai, R.; Nagarajan, K. Advances on quinazoline based congeners for anticancer potential. Curr. Organic Chem., 2021, 25(6), 695-723.
[7]
Ahmad, I. An insight into the therapeutic potential of quinazoline derivatives as anticancer agents. Med. Chem. Commun., 2017, 8(5), 871-885.
[8]
Dhuguru, J.; Skouta, R. Role of indole scaffolds as pharmacophores in the development of anti-lung cancer agents. Molecules, 2020, 25(7), 1615.
[9]
Mir, R.H. Mohi-ud-Din, R.; Wani, T.U.; Dar, M.O.; Shah, A.J.; Lone, B.; Pooja, C.; Masoodi, M.H. Indole: A privileged heterocyclic moiety in the management of cancer. Curr. Organic Chem., 2021, 25(6), 724-736.
Article Metrics
![Wayfinder Image](/images/wayfinder.jpg)